AstraZeneca's Crestor reduces risk of blood clots in the veins - A new analysis from the JUPITER study shows that CRESTOR® (rosuvastatin calcium) 20mg significantly cut the risk of venous …
Pharma News this week
General news: Approvals: Genzyme's stem cell transplant drug Mozobil; Abbott's triglyceride drug TriLipix; Eisai's Lusedra for anesthesia. Novartis' experimental MS drug (oral) looking really good …